SuperGen acquires fellow cancer company Astex Therapeutics in a cash and stock deal valued at approximately $87.4M

Astex Therapeutics Ltd.

U.K. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

SuperGen Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed